Goldenwell Biotech, Inc. (GWLL)

Goldenwell Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.08	0.05	0.05	0.05	0.21	0.25
Cash & Short-Term Investments	0.08	0.05	0.05	0.05	0.21	0.25
Cash Growth	197.46%	-7.19%	15.73%	-78.46%	-14.09%	0.80%
Inventory	0.17	0.17	0.17	0.18	0.2	-
Total Current Assets	0.25	0.22	0.23	0.22	0.41	0.25
Property, Plant & Equipment	-	-	-	0.03	0.05	-
Total Assets	0.25	0.22	0.23	0.25	0.46	0.25
Accounts Payable	-	-	-	-	0.11	-
Current Portion of Leases	-	-	-	0.03	0.05	-
Current Unearned Revenue	0.06	0	0	0	-	-
Total Current Liabilities	0.06	0	0	0.03	0.16	-
Long-Term Debt	0.27	0.27	0.14	0.02	-	-
Other Long-Term Liabilities	-	-	-	-	-0	-
Total Liabilities	0.34	0.27	0.14	0.05	0.16	-
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1.3	1.3	1.3	1.3	0.42	0.33
Retained Earnings	-1.4	-1.36	-1.23	-1.11	-0.13	-0.01
Comprehensive Income & Other	-0	-	-	-	-0	-0.08
Shareholders' Equity	-0.09	-0.05	0.08	0.2	0.3	0.25
Total Liabilities & Equity	0.25	0.22	0.23	0.25	0.46	0.25
Total Debt	0.27	0.27	0.14	0.05	0.05	-
Net Cash (Debt)	-0.2	-0.22	-0.09	0	0.17	0.25
Net Cash Growth	-	-	-	-99.62%	-33.31%	0.80%
Net Cash Per Share	-0.00	-0.00	-0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	99	99	99	99	96	96
Total Common Shares Outstanding	99	99	99	99	96	91.5
Working Capital	0.19	0.22	0.23	0.2	0.25	0.25
Book Value Per Share	-0.00	-0.00	0.00	0.00	0.00	0.00
Tangible Book Value	-0.09	-0.05	0.08	0.2	0.3	0.25
Tangible Book Value Per Share	-0.00	-0.00	0.00	0.00	0.00	0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.